Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Venus Remedies Limited ( (IN:VENUSREM) ) has provided an update.
Venus Remedies Limited has announced the re-lodgement of shares for transfer cum dematerialization in compliance with a SEBI circular, covering the period from July 7 to July 31, 2025. This move is part of a broader regulatory effort to streamline investment processes, potentially impacting the company’s operational efficiency and investor relations by aligning with SEBI’s ease of doing investment initiatives.
More about Venus Remedies Limited
Venus Remedies Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of medicinal products. The company is known for its emphasis on research and development to deliver innovative healthcare solutions.
Average Trading Volume: 6,001
Technical Sentiment Signal: Buy
Current Market Cap: 6.61B INR
For an in-depth examination of VENUSREM stock, go to TipRanks’ Overview page.